Literature DB >> 25529569

Recent advances in peptide-based subunit nanovaccines.

Mariusz Skwarczynski1, Istvan Toth.   

Abstract

Vaccination is the most efficient way to protect humans against pathogens. Peptide-based vaccines offer several advantages over classical vaccines, which utilized whole organisms or proteins. However, peptides alone are not immunogenic and need a delivery system that can boost their recognition by the immune system. In recent years, nanotechnology-based approaches have become one of the most promising strategies in peptide vaccine delivery. This review summarizes knowledge on peptide vaccines and nanotechnology-based approaches for their delivery. The recently reported nano-sized delivery platforms for peptide antigens are reviewed, including nanoparticles composed of polymers, peptides, lipids, inorganic materials and nanotubes. The future prospects for peptide-based nanovaccines are discussed.

Entities:  

Keywords:  adjuvant; dendrimers; lipids; macromolecules; nanoparticles; nanotechnology; peptide vaccine; polymer; self-assembly; vaccine delivery

Mesh:

Substances:

Year:  2014        PMID: 25529569     DOI: 10.2217/nnm.14.187

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  37 in total

1.  Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.

Authors:  Sita Awasthi; Lauren M Hook; Gokul Swaminathan; Tina M Cairns; Benjamin Brooks; Jeffrey S Smith; Noah T Ditto; Marian E Gindy; Andrew J Bett; Amy S Espeseth; Gary H Cohen; Harvey M Friedman
Journal:  Vaccine       Date:  2019-05-29       Impact factor: 3.641

2.  Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.

Authors:  Xi-Xi Cao; Yu-Hong Li; Qian-Lin Ye; Xuan Hu; Tian-Feng Wang; Ming-Wen Fan
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

3.  Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.

Authors:  Na Chen; Pei Zhu; Ting Du; Kai Han; Dang Wang; Jianfeng Ye; Shaobo Xiao; Xiaozhou Ye; Yun Wang
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

4.  The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.

Authors:  Yue Zhang; Pengfei Gu; Adelijiang Wusiman; Shuwen Xu; Haiyu Ni; Tianxin Qiu; Zhenguang Liu; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Int J Nanomedicine       Date:  2020-08-05

Review 5.  An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.

Authors:  Marcin Michalik; Bardya Djahanschiri; Jack C Leo; Dirk Linke
Journal:  Methods Mol Biol       Date:  2022

6.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Developments in Vaccine Adjuvants.

Authors:  Farrhana Ziana Firdaus; Mariusz Skwarczynski; Istvan Toth
Journal:  Methods Mol Biol       Date:  2022

8.  Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity.

Authors:  Shuyun Dong; Sundharraman Subramanian; Kristin N Parent; Mingnan Chen
Journal:  J Control Release       Date:  2020-09-19       Impact factor: 9.776

9.  A Potent Vaccine Delivery System.

Authors:  Guangzu Zhao; Armira Azuar; Istvan Toth; Mariusz Skwarczynski
Journal:  Bio Protoc       Date:  2021-04-05

Review 10.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.